James Hilbert
35 SlideShares 3 Followers 2 Followings
Personal Information
Organization / Workplace
Los Angeles United States
Occupation
Consultant
Website
none
About
not telling
Tags
finance biotech mdv3100 zytiga jnj exel cabozantinib mdvn ogxi lovaza ldl stocks and bonds biotechnology and pharmaceuticals mapp $sngx trading uthr vrtx momenta mnta mnta rpbc biotech inhibitex
See more

Presentations

(11)
See all

Rgen 101510

13 years ago • 500 Views

Dcth isolation perfusion

13 years ago • 1318 Views

Nsclc 2nd line

12 years ago • 852 Views

Novel therapies in hcc

12 years ago • 797 Views

Bmn 110 ph12 results

11 years ago • 652 Views

Phase 2b emerge study of cdx 011

11 years ago • 644 Views

5 understanding some basic trial designs in sarcomas (inclusive a placebo one) prof van der graaf nl

11 years ago • 1100 Views

Company presentation

11 years ago • 457 Views

Asco 2012 abstract_45010_oral_final

11 years ago • 464 Views

Aldoxorubicin p2-sts-01 ctos poster 10-31-13

10 years ago • 1243 Views

Protalix analyst day presentation

10 years ago • 2402 Views

Documents

(24)
See all

Inhx buy nov 2010

13 years ago • 370 Views

Mt200833a

13 years ago • 432 Views

Goldman mnta

13 years ago • 716 Views

Astm restore cli update nov 2010

13 years ago • 300 Views

Clda griffin01

13 years ago • 523 Views

Clda bmo01

13 years ago • 435 Views

Clda roth01

13 years ago • 394 Views

Ariad jeffries jan 2011

13 years ago • 470 Views

Lovenox trial scheduling

13 years ago • 521 Views

Psti needham 4411

13 years ago • 678 Views

Optr 04052011

13 years ago • 386 Views

GS Weekly Options Watch - May 11th

12 years ago • 1291 Views

$PSTI Oppenheimer

12 years ago • 807 Views

Cbli 2011 05 25 barda

12 years ago • 438 Views

$SNGX Nnational.2.1.2010

12 years ago • 365 Views

Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease (Review)

12 years ago • 830 Views

Docetaxel Versus Docetaxel/Cisplatin in NSCLC

12 years ago • 551 Views

12702889

12 years ago • 348 Views

$MAPP Phase 3 results

12 years ago • 474 Views

The combos study an expert interview with william s

12 years ago • 562 Views

1 s2.0-s1470204510701327-main

11 years ago • 472 Views

Transforming time for prostate cancer therapies

11 years ago • 938 Views

Alny

10 years ago • 630 Views

Ttrsc

10 years ago • 705 Views

Likes

(11)
See all

Patents & market exclusivity

GMP EDUCATION : Not for Profit Organization • 11 years ago

The caret Package: A Unified Interface for Predictive Models

NYC Predictive Analytics • 12 years ago

Turbo-Charge Your Analytics with IBM Netezza and Revolution R Enterprise: A Step-by-Step Approach for Acceleration and Innovation

Revolution Analytics • 12 years ago

Using R for Analyzing Loans, Portfolios and Risk: From Academic Theory to Financial Practice

Revolution Analytics • 12 years ago

Applications of R in Business contest: 2012

Revolution Analytics • 12 years ago

RHadoop, R meets Hadoop

Revolution Analytics • 12 years ago

Models Collecting Dust? How to Transform Your Results from Interesting to Impactful

Revolution Analytics • 12 years ago

The Powerful Marriage of Hadoop and R (David Champagne)

Revolution Analytics • 12 years ago

Revolution R - 100% R and More

Revolution Analytics • 12 years ago

Successful Uses of R in Banking

Revolution Analytics • 12 years ago

Scalable Data Analysis in R Webinar Presentation

Revolution Analytics • 12 years ago
Personal Information
Organization / Workplace
Los Angeles United States
Occupation
Consultant
Website
none
About
not telling
Tags
finance biotech mdv3100 zytiga jnj exel cabozantinib mdvn ogxi lovaza ldl stocks and bonds biotechnology and pharmaceuticals mapp $sngx trading uthr vrtx momenta mnta mnta rpbc biotech inhibitex
See more